Evidence map›Paper›PMID 39737205›Full record

ArticleIranian journal of biotechnology2024

Inhibition of Chitinase-3-like Protein 1 Reduced Epithelial-Mesenchymal Transition and Vascular Epithelial Cadherin Expression in Oesophageal Squamous Cell Carcinoma.

Yanzi Qin, Wenjun Zhao, Qicai Li, Zhaogeng Cai, Guowen Wang, Nan Wang, Li Ma

Abstract read
In one paragraph

Article in Iranian journal of biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yanzi QinDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Wenjun ZhaoDepartment of Emergency Internal Medicine, The Third the People's Hospital of Bengbu, Bengbu 233000, China.
Qicai LiDepartment of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Bengbu Medical University,Bengbu 233000, China.
Zhaogeng CaiDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Guowen WangDepartment of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Bengbu Medical University,Bengbu 233000, China.
Nan WangDepartment of Critical Care Medicine, The Fourth Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Li MaDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oesophageal cancer (EC) is one of the common malignant tumors, and the prognosis of patients is poor. Further exploration of EC pathogenesis remains warranted. Objective: The relationship between vascular epithelial cadherin (VE-cadherin) and chitinase-3-like protein 1 (CHI3L1) in EC is currently unknown. To further explore the relationship, immunohistochemical staining was performed to detect the expression level of CHI3L1 and VE-cadherin in oesophageal squamous cell carcinoma ( ESCC). Materials and Methods: Small interfering RNAs (siRNAs) inhibited CHI3L1 expression in KYSE-150 and TE1 cells. Western blot and quantitative fluorescence polymerase chain reaction were used to detect the levels of CHI3L1, VE-cadherin and epithelial-mesenchymal transition (EMT)-related proteins Results: High levels of CHI3L1 and VE-cadherin expression were closely associated with the progression of ESCC; the pathologic tumour-node-metastasis stage was also closely related with the progression of ESCC ( Conclusions: Chitinase-3-like protein 1 could promote the EMT of ESCC, and the inhibition of CHI3L1 decreases the expression of VE-cadherin, which inhibits tumour angiogenesis and tumour progression in ESCC.

Indexed as

CHI3L1Oesophageal cancerSquamous cell carcinomaVE-cadherin

Identifiers

PMID39737205
PMCPMC11682521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.